In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Allon Therapeutics Inc.

Division of Endo International PLC
www.allontherapeutics.com

Latest From Allon Therapeutics Inc.

ApoE Mounts A Comeback In Alzheimer’s

New research has identified ApoE as a potential direct regulator of transcription, suggesting a broad role for the molecule in the study of Alzheimer’s disease that could explain why the usual strategies of trying to break up accumulations of amyloid beta or regulate tau hyperphosphorylation have failed to adequately treat symptoms or cure the disease.

BioPharmaceutical Research and Development Strategies

Deals Shaping The Medical Industry, September 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device

INTERVIEW: ADDF optimistic on Alzheimer's drugs despite recent setbacks

Howard Fillit, executive director and chief scientific officer at the Alzheimer's Drug Discovery Foundation (ADDF) in New York, is optimistic about the Alzheimer's field despite multiple high-profile setbacks for late-stage therapeutics seeking to slow or stop progression of the disease.

Metabolic Disorders Cardiovascular

Genting places $112m bet on TauRx to untangle Alzheimer's

As the largest operator of casinos and resorts in Malaysia, Genting Berhad is used to the odds favoring the house. It is now hoping that its latest bet in healthcare will also pay off handsomely.

Neurology Singapore
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Endo International PLC
  • Senior Management
  • Gordon C McCauley, Pres. & CEO
    Matthew J Carlyle, CFO
  • Contact Info
  • Allon Therapeutics Inc.
    Phone: (604) 736-0634
    1168 Hamilton St.
    Ste. 506
    Vancouver, V6B 2S2
    Canada
Advertisement
Advertisement
UsernamePublicRestriction

Register